Elan Corporation PLC (ELN.I)
11.64EUR
1 Aug 2013
€0.05 (+0.47%)
€11.64
€11.63
€11.68
€11.53
154,311
340,565
€12.57
€6.83
About
Overall
| Beta: | 0.56 |
| Market Cap (Mil.): | €5,907.28 |
| Shares Outstanding (Mil.): | 511.59 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| ELN.I | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 47.13 | 37.76 |
| EPS (TTM): | -0.46 | -- | -- |
| ROI: | -27.52 | -2.58 | 18.76 |
| ROE: | -52.59 | -2.66 | 19.59 |
US STOCKS-Wall St declines as investors focus on Fed policy meeting
* Fed could signal plans about stimulus, jobs data this week as well
US STOCKS-Wall St declines as investors focus on Fed policy meeting
* Fed could signal plans about stimulus, jobs data this week as well
Deals of the day -- mergers and acquisitions
July 29 - The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Monday:
US STOCKS-Wall Street falls as investors eye Fed statement
* Investors turn focus to data, signals from Fed on stimulus
Drugmaker Perrigo to buy Ireland's Elan for $8.6 billion
DUBLIN - U.S. drugmaker Perrigo agreed to buy Elan for $8.6 billion in a deal that will hand it tax savings from being domiciled in Ireland and royalties from a blockbuster multiple sclerosis treatment.
UPDATE 4-U.S. drugmaker Perrigo to buy Ireland's Elan for $8.6 bln
DUBLIN, July 29 - U.S. drugmaker Perrigo agreed to buy Elan for $8.6 billion in a deal that will hand it tax savings from being domiciled in Ireland and royalties from a blockbuster multiple sclerosis treatment.
US STOCKS-Wall Street set to slip at open beginning busy week
* Drug firm Perrigo to buy Elan; Publicis, Omnicom in merger
US STOCKS-Futures dip ahead of key data, Fed meeting this week
* Perrigo to buy Elan; Lord & Taylor's parent to acquire Saks
US STOCKS-Futures dip before key data, Fed meeting this week
* Perrigo to buy Elan, Lord & Taylor's parent to acquire Saks
M&A deals boost European stocks
* Despite recent wave of deals, M&A activity subdued in 2013
Earnings vs.
Estimates
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: ValuEngine, Inc.
|
$25.00
|
|
Provider: ValuEngine, Inc.
|
$25.00
|
|
Provider: S&P Capital IQ – STARS Reports
|
$127.00
|
|
Provider: Plunkett Research, Ltd.
|
$99.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

